{"data":{"id":"us-wv/w.-va.-code-60a-2-204","jurisdiction":"us-wv","citation":"W. Va. Code § 60A-2-204","heading":"Schedule I.","body":"(a) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section including their isomers, esters, ethers, salts and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation.\n(b) Opiates.\nAcetyl-alpha-methylfentanyl(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-phenylacetamide);\nAcetylmethadol;\nAllylprodine;\nAlphacetylmethadol (except levoalphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM);\nAlphameprodine;\nAlphamethadol;\nAlpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(( propanilido) piperidine);\nAlpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-phenylpropanamide);\nBenzethidine;\nBetacetylmethadol;\nBeta-hydroxyfentanyl(N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide);\nBeta-hydroxy-3-methylfentanyl (other name: N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);\nBetameprodine;\nBetamethadol;\nBetaprodine;\nBrorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one);\nClonitazene;\nDextromoramide;\nDiampromide;\nDiethylthiambutene;\nDifenoxin;\nDimenoxadol;\nDimepheptanol;\nDimethylthiambutene;\nDioxaphetyl butyrate;\nDipipanone;\nEthylmethylthiambutene;\nEtonitazene;\nEtoxeridine;\nFentanyl analog or derivative, as that term is defined in article one of this chapter: Provided, That fentanyl and carfentanil remains a Schedule II substance, as set forth in §60A-2-206 of this code;\nFurethidine;\nHydroxypethidine;\nKetobemidone;\nLevomoramide;\nLevophenacylmorphan;\n3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide);\n3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl) ethyl-4-piperidinyl]-phenylpropanamide);\nMorpheridine;\nN-Methylnorfentanyl (N-(1-Methyl-4-piperidinyl)-N-phenyl-propanamide, monohydrochloride);\nMPPP (1-methyl-4-phenyl-4-propionoxypiperidine);\nNoracymethadol;\nNorlevorphanol;\nNormethadone;\nNorpipanone;\nPara-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide);\nPEPAP(1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);\nPhenadoxone;\nPhenampromide;\nPhenomorphan;\nPhenoperidine;\nPiritramide;\nProheptazine;\nProperidine;\nPropiram;\nRacemoramide;\nThiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide);\nTilidine;\nTrimeperidine.\n(c) Opium derivatives.\nAcetorphine;\nAcetyldihydrocodeine;\nBenzylmorphine;\nCodeine methylbromide;\nCodeine-N-Oxide;\nCyprenorphine;\nDesomorphine;\nDihydromorphine;\nDrotebanol;\nEtorphine (except HCl Salt);\nHeroin;\nHydromorphinol;\nMethyldesorphine;\nMethyldihydromorphine;\nMorphine methylbromide;\nMorphine methylsulfonate;\nMorphine-N-Oxide;\nMyrophine;\nNicocodeine;\nNicomorphine;\nNormorphine;\nPholcodine;\nThebacon.\n(d) Hallucinogenic substances.\nAlpha-ethyltryptamine; some trade or other names: etryptamine; Monase; alpha-ethy-1H-indole-3-ethanamine; 3-(2- aminobutyl) indole; alpha-ET; and AET;\n1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA);\n4-bromo-2, 5-dimethoxy-amphetamine; some trade or other names: 4-bromo-2,5-dimethoxy-alpha-methylphenethylamine; 4-bromo- 2,5-DMA;\n4-Bromo-2,5-dimethoxyphenethylamine; some trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha- desmethyl DOB; 2C-B, Nexus;\nN-(2-Methoxybenzyl)-4-bromo-2, 5-dimethoxyphenethylamine. The substance has the acronym 25B-NBOMe;\n2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe);\n2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe);\n2,5-dimethoxyamphetamine; some trade or other names: 2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA;\n2,5-dimethoxy-4-ethylamphet-amine; some trade or other names: DOET;\n2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7);\n4-methoxyamphetamine; some trade or other names: 4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine; PMA;\n3-Hydoxy-phencyclidine (other name hydroxy PCP);\n5-methoxy-3, 4-methylenedioxy-amphetamine;\n4-methyl-2,5-dimethoxy-amphetamine; some trade and other names: 4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; \"DOM\"; and \"STP\";\n3,4-methylenedioxy amphetamine;\n3,4-methylenedioxymethamphetamine (MDMA);\n3,4-methylenedioxy-N-ethylamphetamine (also known as ( ethyl-alpha-methyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA, MDE, MDEA);\nN-hydroxy-3,4-methylenedioxyamphetamine (also known as ( hydroxy-alpha-methyl-3,4 (methylenedioxy) phenethylamine, and ( hydroxy MDA);\n3,4,5-trimethoxy amphetamine;\n5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT);\nAlpha-methyltryptamine (other name: AMT);\nBufotenine; some trade and other names: 3-(beta-Dimethylaminoethyl)-5-hydroxyindole;3-(2-dimethylaminoethyl) -5-indolol; N, N-dimethylserotonin; 5-hydroxy-N,N- dimethyltryptamine; mappine;\nDiethyltryptamine; sometrade and other names: N, N-Diethyltryptamine; DET;\nDimethyltryptamine; some trade or other names: DMT;\n5-Methoxy-N,N-disopropyltryptamine (5-MeO-DIPT);\nIbogaine; some trade and other names: 7-Ethyl-6, 6 Beta, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H- pyrido [1’, 2’: 1, 2] azepino [5,4-b] indole; Tabernanthe iboga;\nLysergic acid diethylamide;\nMarihuana; Marijuana (Cannabis, sp.);\nMescaline;\nParahexyl-7374; some trade or other names: 3-Hexyl -1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b,d] pyran; Synhexyl;\nPeyote; meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, immediate derivative, mixture, or preparation of such plant, its seeds or extracts;\nN-ethyl-3-piperidyl benzilate;\nN-methyl-3-piperidyl benzilate;\nPsilocybin; except as provided for in §60A-2-201(g) of this code;\nPsilocyn;\nTetrahydrocannabinols; synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, immediate derivatives and their isomers with similar chemical structure and pharmacological activity including, but not limited to the following:\ndelta-1 Cis or trans tetrahydrocannabinol, and their optical isomers;\ndelta-6 Cis or trans tetrahydrocannabinol, and their optical isomers;\ndelta-3,4 Cis or trans tetrahydrocannabinol, and its optical isomers;\ndelta-8 Cis or trans tetrahydrocannabinol and its optical isomers; and\ndelta-10 Cis or trans tetrahydrocannabinol and its optical isomers;\n(Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered.)\nDelta-8-tetrahydrocannabinol-O (delta-8-THC-0), Delta-9-tetrahydrocannabinol (delta-9-THC-0) and Synthetic and non-naturally occurring cannabinoids.\nThe provisions of this section related to tetrahydrocannabinols are inapplicable to products or substances lawfully manufactured, distributed, or possessed under the provisions of §19-12E-1 et seq. and chapter 16H of this code.\nEthylamine analog of phencyclidine; some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;\nPyrrolidine analog of phencyclidine; some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;\nThiophene analog of phencyclidine; some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine; TPCP, TCP;\n1[1-(2-thienyl)cyclohexyl]pyrroldine; some other names: TCPy;\n4-methylmethcathinone (Mephedrone);\n3,4-methylenedioxypyrovalerone (MDPV);\n2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E);\n2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D);\n2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);\n2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I);\n2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2);\n2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4);\n2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);\n2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N);\n2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P);\n3,4-Methylenedioxy-N-methylcathinone (Methylone);\n2,5-dimethoxy-4-(n)-propyltghiophenethylamine (2C-T-7, itsoptical isomers, salts and salts of isomers;\n5-methoxy-N,N-dimethyltryptamine some trade or other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT(5-MeO-DMT);\nAlpha-methyltryptamine (other name: AMT);\n5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT);\nSynthetic Cannabinoids as follows:\n2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol) { also known as CP 47,497 and homologues} ;\nrel-2-[(1S,3R)-3-hydroxycyclohexyl] -5-(2-methylnonan-2-yl)phenol { also known as CP 47,497-C8 homolog} ;\n[(6aR)-9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a, 7,10,10a-tetrahydrobenzo[c]chromen-1-ol)] { also known as HU-210} ;\n(dexanabinol);\n(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzol[c]chromen-1-ol) { also known as HU-211} ;\n1-Pentyl-3-(1-naphthoyl)indole { also known as JWH-018} ;\n1-Butyl-3-(1-naphthoyl)indole { also known as JWH-073} ;\n(2-methyl-1-propyl-1H-indol-3-yl)-1-napthalenyl-methanone { also known as JWH-015} ;\n(1-hexyl-1H-indol-3-yl)-1-naphthalenyl-methanone { also known as JWH-019} ;\n[1-[2-(4-morpholinyl) ethyl] -1H-indol-3-yl]-1-naphthalenyl-methanone { also known as JWH-200} ;\n1-(1-pentyl-1H-indol-3-yl)-2-(3-hydroxyphenyl)-ethanone { also known as JWH-250} ;\n2-((1S,2S,5S)-5-hydroxy-2-(3-hydroxtpropyl)cyclohexyl) -5-(2-methyloctan-2-yl)phenol {also known as CP 55,940} ;\n(4-methyl-1-naphthalenyl) (1-pentyl-1H-indol-3-yl)-methanone { also known as JWH-122};\n(4-methyl-1-naphthalenyl) (1-pentyl-1H-indol-3-yl)-methanone { also known as JWH-398;\n(4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone { also known as RCS-4} ;\n1-(1-(2-cyclohexylethyl) -1H-indol-3-yl) -2-(2-methoxyphenyl) ethanone { also known as RCS-8} ;\n1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081);\n1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201); and\n1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694).\nSynthetic cannabinoids:\nCP 47,497 AND homologues, 2-[(1R,3S)-3-Hydroxycyclohexyl]-5-(2-methyloctan-2-YL)phenol);\nHU-210, [(6AR,10AR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-Methyloctan-2-YL)-6A,7,10, 10A-tetrahydrobenzo[C] chromen-1-OL)];\nHU-211, (dexanabinol, (6AS,10AS)-9-(hydroxymethyl)-6,6-Dimethyl-3-(2-methyloctan-2-YL)-6A,7,10,10atetrahydrobenzo[ C]chromen-1-OL);\nJWH-018, 1-pentyl-3-(1-naphthoyl)indole;\nJWH-019, 1-hexyl-3-(1-naphthoyl)indole;\nJWH-073, 1-butyl-3-(1-naphthoyl)indole;\nJWH-200, (1-(2-morpholin-4-ylethyl)indol-3-yl)- Naphthalen-1-ylmethanone;\nJWH-250, 1-pentyl-3-(2-methoxyphenylacetyl)indole.]\nMethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (5F-ADB);\nMethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (5F-AMB);\nMethyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (FUB-AMB);\nN-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (5F-APINACA);\nN-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (ADB-FUBINACA);\nMethyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (MDMB-CHMICA);\nMethyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (MDMB-FUBINACA);\nTetrahydrocannabinols:\nDELTA-1 CIS OR trans tetrahydrocannabinol and their optical isomers.\nDELTA-6 CIS OR trans tetrahydrocannabinol and their optical isomers.\nDELTA-3,4 CIS or their trans tetrahydrocannabinol and their optical isomers.\nSynthetic Phenethylamines\n2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe/ 2C-I-NBOMe);\n2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe/2C-C-NBOMe);\n2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe/ 2C-B-NBOMe);\nSynthetic Opioids (including their isomers, esters, ethers, salts and salts of isomers, esters and ethers):\nN-(1-phenethylpiperidin-4-yl)-N-phenylacetamide (acetyl fentanyl);\nfuranyl fentanyl;\n3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (also known as U-47700);\nN-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, also known as N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide, (butyryl fentanyl);\nN-[1-[2-hydroxy-2-(thiophen-2-yl)ethylpiperidin-4-yl]-N-phenylpropionamide, also known as N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide, (beta-hydroxythiofentanyl);\nN-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryl fentanyl);\nN-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl fentanyl);\nN-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide (cyclopropyl fentanyl);\n2-(2,4-dichlorophenyl)-N-((1S,2S)-2-(dimethylamino)cyclohexyl)-N-methylacetamide (also known as U-48800);\nTrans-3,4-dichloro-N-[2-(diethylamino)cyclohexyl]-N-methyl-benzamide (also known as U-49900);\nTrans-3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methyl-benzeneacetamide (also known as U-51754);\n2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (butonitazene);\n2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (etodesnitazene);\nN,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (flunitazene);\nN,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (metodesnitazene);\nN,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (metonitaze);\n2-(4-ethoxybenzyl)5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1 H-benzimidazole (N-pyrrolidino etonitazene, etonitazepyne);\nN,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (protonitazene);\nN-pyrrolidino etonitazene;\nEtodesnitazene;\nIsotonitazene;\nProtonitazene;\nMetonitazene;\nButonitazene;\nMetodesnitazene;\nFlunitazene;\nOpioid Receptor Agonist\n2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one)\nAH-7921 (3,4-dichloro-N-(1dimethylamino)cyclohexylmethyl]benzamide).\nNaphthoylindoles or any compound containing a 3-(-1-Napthoyl) indole structure with substitution at the nitrogen atom of the indole ring whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent. This shall include the following:\nJWH 015;\nJWH 018;\nJWH 019;\nJWH 073;\nJWH 081;\nJWH 122;\nJWH 200;\nJWH 210;\nJWH 398;\nAM 2201; and\nWIN 55,212.\nNaphylmethylindoles or any compound containing a 1hindol-3-yl-(1-naphthyl) methane structure with a substitution at the nitrogen atom of the indole ring whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent. This shall include, but not be limited to, JWH 175 and JWH 184.\nNaphthoylpyrroles or any compound containing a 3-(1- Naphthoyl) pyrrole structure with substitution at the nitrogen atom of the pyrrole ring whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent. This shall include, but not be limited to, JWH 147 and JWH 307.\nNaphthylmethylindenes or any compound containing a Naphthylideneindene structure with substitution at the 3- Position of the indene ring whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent. This shall include, but not be limited to, JWH 176.\nPhenylacetylindoles or any compound containing a 3- Phenylacetylindole structure with substitution at the nitrogen atom of the indole ring whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. This shall include the following:\nRCS-8, SR-18 OR BTM-8;\nJWH 250;\nJWH 203;\nJWH 251; and\nJWH 302.\nCyclohexylphenols or any compound containing a 2-(3-hydroxycyclohexyl) phenol structure with a substitution at the 5-position of the phenolic ring whether or not substituted in the cyclohexyl ring to any extent. This shall include the following:\nCP 47,497 and its homologues and analogs;\nCannabicyclohexanol; and\nCP 55,940.\nBenzoylindoles or any compound containing a 3-(benzoyl) indole structure with substitution at the nitrogren atom of the indole ring whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. This shall include the following:\nAM 694;\nPravadoline WIN 48,098;\nRCS 4; and\nAM 679.\n[2,3-dihydro-5 methyl-3-(4-morpholinylmethyl)pyrrolo [1,2,3-DE]-1, 4-benzoxazin-6-YL]-1-napthalenymethanone. This shall include WIN 55,212-2.\nDibenzopyrans or any compound containing a 11-hydroxydelta 8-tetrahydrocannabinol structure with substitution on the 3-pentyl group. This shall include HU-210, HU-211, JWH 051, and JWH 133.\nAdamantoylindoles or any compound containing a 3-(-1-Adamantoyl) indole structure with substitution at the nitrogen atom of the indole ring whether or not further substituted in the adamantoyl ring system to any extent. This shall include AM1248.\nTetramethylcyclopropylindoles or any compound containing A 3-tetramethylcyclopropylindole structure with substitution at the nitrogen atom of the indole ring whether or not further substituted in the indole ring to any extent and whether or not substituted in the tetramethylcyclopropyl ring to any extent. This shall include UR-144 and XLR-11.\nN-(1-Adamantyl)-1-pentyl-1h-indazole-3-carboxamide. This shall include AKB48.\nAny other synthetic chemical compound that is a cannabinoid receptor type 1 agonist as demonstrated by binding studies and functional assays that is not listed in Schedules II, III, IV, and V, not federal Food and Drug Administration-approved drug or used within legitimate, approved medical research. Since nomenclature of these substances is not internationally standardized, any immediate precursor or immediate derivative of these substances shall be covered.\nTryptamines:\n5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT);\n4-hydroxy-N,N-diisopropyltryptamine (4-HO-DiPT);\n4-hydroxy-N-methyl-N-isopropyltryptamine (4-HO-MiPT);\n4-hydroxy-N-methyl-N-ethyltryptamine (4-HO-MET);\n4-acetoxy-N,N-diisopropyltryptamine (4-AcO-DiPT);\n5-methoxy-α-methyltryptamine (5-MeO-AMT);\n4-methoxy-N,N-Dimethyltryptamine (4-MeO-DMT);\n4-hydroxy Diethyltryptamine (4-HO-DET);\n5-methoxy-N,N-diallyltryptamine (5-MeO-DALT);\n4-acetoxy-N,N-Dimethyltryptamine (4-AcO DMT);\n4-hydroxy Diethyltryptamine (4-HO-DET);\nFDU-PB-22 (1-Naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate);\nFUB-PB-22 (Quinolin-8-yl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate);\n5-Fluoro-MN-24 (1-(5-Fluoropentyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide);\nMN-24 (N-(naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide);\nSDB-005 (Naphthalen-1-yl 1-pentyl-1H-indazole-3-carboxylate);\nSDB-006 (1-Pentyl-N-(phenylmethyl)-1H-indole-3-carboxamide);\nMethyl-Ethylaminopentiophenone;\nFUB-AMB (Methyl(1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate);\n5-Fluoro-SDB-005 Indole (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate);\n5F-AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide);\nMMB-CHMICA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoat);\nMN-24 (N-(naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide);\nSDB-005 (Naphthalen-1-yl 1-pentyl-1H-indazole-3-carboxylate);\nSDB-006 (1-Pentyl-N-(phenylmethyl)-1H-indole-3-carboxamide);\nEthcathinone (2-(ethylamino)-1-phenyl-1-propanone, monohydrochloride);\nMethyl-Ethylaminopentiophenone;\nFUB-AMB (Methyl(1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate);\n5-Fluoro-SDB-005 Indole (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate);\n5F-AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide);\nMMB-CHMICA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoat);\nBromazolam (8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine);\nClonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4 H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine);\nCloniprazepam (5-(2-chlorophenyl)-1-(cyclopropylmethyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one);\nEtizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a][1,4]diazepine);\nFlualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine);\nFlubromazepam (7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one);\nFlubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine);\nFlunitrazolam (6-(2-fluorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine);\nNifoxipam (5-(2-fluorophenyl)-1,3-dihydro-3-hydroxy-7-nitro-2H-1,4-benzodiazepin-2-one) ;\nNitrazolam (1-methyl-8-nitro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine); and\nPyrazolam (8-bromo-1-methyl-6-(2-pyridinyl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine).\n(e) Depressants.\n4-CN-CUMYL-BUTINACA (1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide);\nAlpha-Phenylacetoacetonitrile (3-Oxo-2-phenylbutanenitrile);\n2-Fluoro Deschloroketamine (2-(2-Fluorophenyl)-2-(methylamino)-cyclohexanone, monohydrochloride);\n4-MEAP (2-(Ethylamino)-1-(4-methylphenyl)pentan-1-one);\nMecloqualone;\nMethaqualone;\nBromazolam (8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine);\nClonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4 H-[1,2,4]triazolo[4,3 a][1,4]benzodiazepine);\nCloniprazepam (5-(2-chlorophenyl)-1-(cyclopropylmethyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one);\nEtizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a][1,4]diazepine);\nFlualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine);\nFlubromazepam (7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one);\nFlubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine);\nFlunitrazolam (6-(2-fluorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine);\ngamma-hydroxybutyric acid (some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate);\nNifoxipam (5-(2-fluorophenyl)-1,3-dihydro-3-hydroxy-7-nitro-2H-1,4-benzodiazepin-2-one);\nNitrazolam (1-methyl-8-nitro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine);\nPyrazolam (8-bromo-1-methyl-6-(2-pyridinyl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine);\nDiclazepam (7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one); and\nDeschloroetizolam (2-Ethyl-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine);\n(f) Stimulants.\nAminorex; some other names: aminoxaphen; 2-amino-5- phenyl-2-oxazoline; or 4,5-dihydro-5-phenyl-2-oxazolamine;\n4,4'-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine);\nCathinone; some trade or other names: 2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone, 2-aminopropiophenone and norephedrone;\nEthylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate);\nFenethylline;\nMesocarb (N-phenyl-N ′-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate);\nMethcathinone, its immediate precursors and immediate derivatives, its salts, optical isomers and salts of optical isomers; some other names: (2-(methylamino)-propiophenone; alpha-\n(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-methylaminopropiophenone; monomethylpropion; 3,4-methylenedioxypyrovalerone and/or mephedrone;3,4-methylenedioxypyrovalerone (MPVD); ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432;\n( -) cis-4-methylaminorex; (( -)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);\nN-ethylamphetamine;\nN,N-dimethylamphetemine; also known as N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine;\nAlpha-pyrrolidinopentiophenone, also known as alpha-PVP, optical isomers, salts and salts of isomers;\nSubstituted amphetamines:\n2-Fluoroamphetamine;\n3-Fluoroamphetamine;\n4-Fluoroamphetamine;\n2-chloroamphetamine;\n3-chloroamphetamine;\n4-chloroamphetamine;\n2-Fluoromethamphetamine;\n3-Fluoromethamphetamine;\n4-Fluoromethamphetamine;\n4-chloromethamphetamine;\nEthcathinone (2-(ethylamino)-1-phenyl-1-propanone, monohydrochloride);\nAlpha-PHP (1-Phenyl-2-(pyrrolidin-1-yl)hexan-1-one);\nMPHP (1-(4-Methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one);\nPV8 (1-Phenyl-2-(pyrrolidin-1-yl)heptan-1-one);\n4-Chloro-Alpha-PVP (1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one);\nN-Ethylhexedrone (2-(Ethylamino)-1-phenylhexan-1-one);\nMethoxetamine (2-(Ethylamino)-2-(3-methoxyphenyl)-cyclohexanone); and\n3-Fluorophenmetrazine (2-(3-Fluorophenyl)-3-methylmorpholine);\n(g) Temporary listing of substances subject to emergency scheduling. Any material, compound, mixture, or preparation which contains any quantity of the following substances:\nN-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical isomers, salts, and salts of isomers;\nN-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl), its optical isomers, salts, and salts of isomers.\nN-benzylpiperazine, also known as BZP;\nCyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide);\n4-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]-butyramide);\nIsobutyryl fentanyl (2-methyl-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-propanamide);\nMethoxyacetyl fentanyl (2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-acetamide);\n3-methylbutyryl fentanyl (N-[3-methyl-1-(2-phenylethyl)piperidin-4-yl]-N-phenylbutyramide);\n4-methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide);\nOcfentanil (N-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)piperidin-4-yl]-acetamide);\nTetrahydrofuran fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide); and\nValeryl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]pentanamide).\n(h) The following controlled substances are included in Schedule I:\nSynthetic Cathinones or any compound, except bupropion or compounds listed under a different schedule, or compounds used within legitimate and approved medical research, structurally derived from 2-Aminopropan-1-one by substitution at the 1-position with Monocyclic or fused polycyclic ring systems, whether or not the compound is further modified in any of the following ways:\nBy substitution in the ring system to any extent with Alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide substituents whether or not further substituted in the ring system by one or more other univalent substituents;\nBy substitution at the 3-position with an acyclic alkyl substituent;\nBy substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl or methoxybenzyl groups;\nBy inclusion of the 2-amino nitrogen atom in a cyclic structure; or\nAny other synthetic chemical compound that is a cannabinoid receptor type 1 agonist as demonstrated by binding studies and functional assays that is not listed in Schedules II, III, IV, and V, not federal Food and Drug Administration-approved drug or used within legitimate, approved medical research.","path":["CHAPTER 60A. UNIFORM CONTROLLED SUBSTANCES ACT.","ARTICLE 2. STANDARDS AND SCHEDULES."],"source_url":"https://code.wvlegislature.gov/60A-2-204/","current_through":"as of 2026-08-03; contains at least the enactments of the 2026 Regular Session","vintage":"","retrieved_at":"2026-09-06T00:31:17Z","sha256":"5b864fe8a122a61ff96e5e30605b93643d9dca56ceda6a48fbd352a5e291173d","source_id":"us-wv","stale":true,"prev":"us-wv/w.-va.-code-60a-2-203","next":"us-wv/w.-va.-code-60a-2-205"},"notice":"GroundRules: Original legal text. Not legal advice."}